These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33896472)

  • 1. Opioid Use in the Nondialysis Chronic Kidney Disease Population.
    Zhuo M; Triantafylidis LK; Li J; Paik JM
    Semin Nephrol; 2021 Jan; 41(1):33-41. PubMed ID: 33896472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Management in Older Adults with Chronic Kidney Disease: A Review.
    Owsiany MT; Hawley CE; Triantafylidis LK; Paik JM
    Am J Med; 2019 Dec; 132(12):1386-1393. PubMed ID: 31295441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Management in CKD.
    Lu E; Schell JO; Koncicki HM
    Am J Kidney Dis; 2021 May; 77(5):786-795. PubMed ID: 33500128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain management in patients with chronic kidney disease and end-stage kidney disease.
    Roy PJ; Weltman M; Dember LM; Liebschutz J; Jhamb M;
    Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):671-680. PubMed ID: 32941189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid prescribing practices in chronic kidney disease: a population-based cohort study.
    Molnar AO; Bota SE; Naylor K; Nash DM; Smith G; Suri RS; Sood MM; Gomes T; Garg AX
    Nephrol Dial Transplant; 2022 Nov; 37(12):2408-2417. PubMed ID: 34888696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong opioids and non-cancer chronic pain in Catalonia. An analysis of the family physicians prescription patterns.
    Perelló Bratescu A; Adriyanov B; Dürsteler C; Sisó-Almirall A; Álvarez Carrera MA; Riera Nadal N
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Feb; 67(2):68-75. PubMed ID: 31740046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescription in Patients With Chronic Kidney Disease: A Systematic Review of Comparing Safety and Efficacy of Opioid Use in Chronic Kidney Disease Patients.
    Odoma VA; Pitliya A; AlEdani E; Bhangu J; Javed K; Manshahia PK; Nahar S; Kanda S; Chatha U; Mohammed L
    Cureus; 2023 Sep; 15(9):e45485. PubMed ID: 37727840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.
    Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G
    Curr Med Res Opin; 2014 Aug; 30(8):1579-87. PubMed ID: 24689806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.
    van Ojik AL; Jansen PA; Brouwers JR; van Roon EN
    Drugs Aging; 2012 Aug; 29(8):615-25. PubMed ID: 22765848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment.
    Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):587-591. PubMed ID: 28101968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Use in Chronic Pain Patients with Chronic Kidney Disease: A Systematic Review.
    Nagar VR; Birthi P; Salles S; Sloan PA
    Pain Med; 2017 Aug; 18(8):1416-1449. PubMed ID: 28339928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beliefs and attitudes about prescribing opioids among healthcare providers seeking continuing medical education.
    Hooten WM; Bruce BK
    J Opioid Manag; 2011; 7(6):417-24. PubMed ID: 22320023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of Ontario primary care physicians' experiences with opioid prescribing.
    Wenghofer EF; Wilson L; Kahan M; Sheehan C; Srivastava A; Rubin A; Brathwaite J
    Can Fam Physician; 2011 Mar; 57(3):324-32. PubMed ID: 21402971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence.
    Tournebize J; Gibaja V; Muszczak A; Kahn JP
    Pain Pract; 2016 Mar; 16(3):370-83. PubMed ID: 25865462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.